The inhibitory effects of ephrin A1 correlate with a disruption of EphA2-AKT complexes and loss of P-EphA2S897, emphasizing the importance of AKT activation and EphA2-AKT interaction for EphA2 oncogenic functions and support of GBM invasiveness. Here, EPHA2 is linked to glioblastoma.